[1]
Kario K. Essential Manual on Perfect 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension: Up-to-date for Anticipation Medicine. Wiley-Blackwell, Tokyo, Japan 2018; pp. 1-309.
[2]
Kario K, Wang JG. Could 130/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of asian populations? Hypertension 2018; 71: 979-84.
[3]
Chia YC, Buranakitjaroen P, Chen CH, et al. HOPE Asia Network. Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia Network. J Clin Hypertens 2017; 19: 1192-201.
[4]
Kario K, Tomitani N, Kanegae H, et al. Development of a new ICT-based multisensor blood pressure monitoring system for use in hemodynamic biomarker-initiated anticipation medicine for cardiovascular disease: The National IMPACT Program Project. Prog Cardiovasc Dis 2017; 60: 435-49.
[5]
Kario K. New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens 2016; 29: 14-6.
[6]
Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol 2013; 9: 726-38.
[7]
Kario K. Systemic hemodynamic atherothrombotic syndrome: a blind spot in the current management of hypertension. J Clin Hypertens 2015; 17: 328-31.
[8]
Kario K. Hemodynamic arteriosclerotic syndrome - A vicious cycle of hemodynamic stress and vascular disease. J Clin Hypertens 2018; 20: 1073-7.
[9]
Kario K. Systemic hemodynamic atherothrombotic syndrome (SHATS): Diagnosis and severity assessment score. J Clin Hypertens 2019; 21: 1011-5.
[10]
Kario K, Chirinos JA, Townsend RR, et al. Systemic Hemodynamic Atherothrombotic Syndrome (SHATS) – Coupling vascular disease and blood pressure variability: Proposed concept from pulse of Asia. Prog Cardiovasc Dis 2019. in press
[11]
Kario K, Kanegae H, Oikawa T, Suzuki K. Hypertension is predicted by both large and small artery disease: A large population-based study in normotensive adults. Hypertension 2019; 73: 75-83.
[12]
Kario K. Global impact of 2017 American Heart Association/ American College of Cardiology Hypertension Guidelines: A perspective from Japan. Circulation 2018; 137: 543-5.
[13]
Kario K, Thijs L, Staessen JA. Blood pressure measurement and treatment decisions. Circ Res 2019; 124: 990-1008.
[14]
Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-5.
[15]
Kario K, Shimbo D, Hoshide S, et al. Emergence of home blood pressure-guided management of hypertension based on global evidence. Hypertension 2019. in press
[16]
Asayama K, Ohkubo T, Metoki H, et al. Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res 2012; 35: 1102-10.
[17]
Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: Primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 2014; 64: 989-96.
[18]
Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease: The HONEST study. J Am Coll Cardiol 2016; 67: 1519-27.
[19]
Kario K, Iwashita M, Okuda Y, et al. Morning home blood pressure and cardiovascular events in Japanese hypertensive patients. Hypertension 2018; 72: 854-61.
[20]
Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K. Day-by-Day variability of home blood pressure and incident cardiovascular disease in clinical practice: The J-HOP study (Japan Morning Surge-Home Blood Pressure). Hypertension 2018; 71: 177-84.
[21]
Hoshide S, Yano Y, Haimoto H, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: The Japan morning surge-home blood pressure study. Hypertension 2016; 68: 54-61.
[22]
Fujiwara T, Yano Y, Hoshide S, Kanegae H, Kario K. Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a Japanese ceneral practice population. JAMA Cardiol 2018; 3: 583-90.
[24]
Kario K, Kanegae H, Tomitani N, et al. on behalf of the J-HOP study group. Nighttime blood pressure measured by home blood pressure monitoring as an independent predictor of cardiovascular events in general practice: The J-HOP Nocturnal BP Study. Hyperetnsion 2019; 73: 1240-8.
[25]
Kandzari DE, Böhm M, Mahfoud F, et al. SPYRAL HTN-ON MED Trial Investigators. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 2018; 391(10137): 2346-55.
[26]
Townsend RR, Mahfoud F, Kandzari DE, et al. SPYRAL HTN-OFF MED trial investigators. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): A randomised, sham-controlled, proof-of-concept trial. Lancet 2017; 390: 2160-70.
[27]
Kario K, Weber MA, Mahfoud F, et al. Changes in 24-hour patterns of blood pressure in hypertension following renal denervation therapy. Hypertension 2019. in press
[28]
Kario K, Böhm M, Mahfoud F, et al. Twenty-four-hour ambulatory blood pressure reduction patterns after renal denervation in the SPYRAL HTN-OFF MED trial. Circulation 2018; 138: 1602-4.
[29]
Kario K, Yamamoto E, Tomita H, et al. on behalf of the. SYMPLICITY HTN-Japan Investigators. Sufficient and persistent blood pressure reduction in the final long-term results from SYMPLICITY HTN-Japan: Safety and efficacy of renal denervation at 3 years. Circ J 2019; 83: 622-9.
[30]
Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect of Catheter-based renal denervation on morning and nocturnal blood pressure: Insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension 2015; 66: 1130-7.
[31]
Kario K, Bhatt DL, Kandzari DE, et al. Impact of renal denervation on patients with obstructive sleep apnea and resistant hypertension - Insights from the SYMPLICITY HTN-3 Trial. Circ J 2016; 80: 1404-12.
[32]
Kario K. Differential approaches are much needed for “real world” management of hypertension in the era of “hypertension paradox”. Curr Hypertens Rev 2018; 14(1): 2-5.
[33]
Kario K, Kim BK, Aoki J, et al. Renal denervation in Asia: Consensus statement of the Asia Renal Denervation Consortium (ARDeC). Submitted
[34]
Kario K. Home blood pressure-guided anticipation management of hypertension: Effective to the gap between the guidelines and the individualized medicine. Curr Hypertens Rev 2019; 15: 2-6.
[35]
Kario K, Chen CH, Park S, et al. Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics. Hypertension 2018; 71: 375-82.
[36]
Kario K. HOPE Asia (Hypertension Cardiovascular Outcome Prevention and Evidence in Asia) Network. The HOPE Asia Network for “zero” cardiovascular events in Asia. J Clin Hypertens 2018; 20: 212-4.
[37]
Sogunuru GP, Kario K, Shin J, et al. HOPE Asia Network. Morning surge in blood pressure and blood pressure variability in Asia: Evidence and statement from the HOPE Asia Network. J Clin Hypertens (Greenwich) 2019; 21: 324-34.
[38]
Turana Y, Tengkawan J, Chia YC, et al. Hypertension and dementia: A comprehensive review from the HOPE Asia Network. J Clin Hypertens (Greenwich) 2019; 21: 1091-8.
[39]
Park S, Buranakitjaroen P, Chen CH, et al. HOPE Asia Network. Expert panel consensus recommendations for home blood pressure monitoring in Asia: The Hope Asia Network. J Hum Hypertens 2018; 32: 249-58.
[40]
Kario K, Park S, Buranakitjaroen P, et al. Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network. J Clin Hypertens 2018; 20: 456-61.
[41]
Kario K, Tomitani N, Buranakitjaroen P, et al. HOPE Asia Network. Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regions. J Clin Hypertens 2018; 20: 33-8.
[42]
Kario K, Tomitani N, Buranakitjaroen P, et al. on behalf of the HOPE Asia Network. Home blood pressure control status in 2017-2018 for hypertension specialist centers. J Clin Hypertens 2018; 20: 1686-95.
[43]
Kario K, Shin J, Chen CH, et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia Network. J Clin Hypertens 2019; 21(9): 1250-83.
[44]
Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107: 1401-6.
[45]
Kario K. Morning surge in blood pressure and cardiovascular risk - evidence and perspectives. Hypertension 2010; 56: 765-73.
[46]
Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-5.
[47]
Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-7.
[48]
Fujiwara T, Hoshide S, Kanegae H, Nishizawa M, Kario K. Reliability of morning, before-dinner, and at-bedtime home blood pressure measurements in patients with hypertension. J Clin Hypertens 2018; 20: 315-23.
[49]
Wang JG, Kario K, Chen CH, et al. Management of morning hypertension: A consensus statement of an Asian expert panel. J Clin Hypertens 2018; 20: 39-44.
[50]
Wang JG, Kario K, Park JB, Chen CH. Morning blood pressure monitoring in the management of hypertension. J Hypertens 2017; 35: 1554-63.
[51]
Kario K. Evidence and perspectives on the 24-hour management of hypertension: Hemodynamic biomarker-initiated ‘anticipation medicine’ for Zero cardiovascular event. Prog Cardiovasc Dis 2016; 59: 262-81.
[52]
Kario K, Tomitani N, Kanegae H, Yasui N, Nagai R, Harada H. The further development of out-of-office BP monitoring: Japan’s ImPACT Program Project’s achievements, impact, and direction. J Clin Hypertens 2019; 21: 344-9.
[53]
Kario K. Disaster hypertension - its characteristics, mechanism, and management. Circ J 2012; 76: 553-62.
[54]
Hoshide S, Nishizawa M, Okawara Y, et al. Salt intake and risk of disaster hypertension among evacuees in a shelter after the great East Japan earthquake. Hypertension 2019; 74(3): 564-71.
[55]
Kario K, Nishizawa M, Hoshide S, et al. Development of a disaster cardiovascular prevention network. Lancet 2011; 378: 1125-7.
[56]
Nishizawa M, Hoshide S, Okawara Y, Matsuo T, Kario K. Strict blood pressure control achieved using an ICT-based home blood pressure monitoring system in a catastrophically damaged area after a disaster. J Clin Hypertens 2017; 19: 26-9.
Article Metrics
9